151 related articles for article (PubMed ID: 9950283)
1. In vitro and in vivo evaluation of the enhancing activity of glycyrrhizin on the intestinal absorption of drugs.
Imai T; Sakai M; Ohtake H; Azuma H; Otagiri M
Pharm Res; 1999 Jan; 16(1):80-6. PubMed ID: 9950283
[TBL] [Abstract][Full Text] [Related]
2. Absorption-enhancing effect of glycyrrhizin induced in the presence of capric acid.
Imai T; Sakai M; Ohtake H; Azuma H; Otagiri M
Int J Pharm; 2005 Apr; 294(1-2):11-21. PubMed ID: 15814227
[TBL] [Abstract][Full Text] [Related]
3. Effects of absorption enhancers on the transport of model compounds in Caco-2 cell monolayers: assessment by confocal laser scanning microscopy.
Sakai M; Imai T; Ohtake H; Azuma H; Otagiri M
J Pharm Sci; 1997 Jul; 86(7):779-85. PubMed ID: 9232516
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous use of sodium deoxycholate and dipotassium glycyrrhizinate enhances the cellular transport of poorly absorbed compounds across Caco-2 cell monolayers.
Sakai M; Imai T; Ohtake H; Azuma H; Otagiri M
J Pharm Pharmacol; 1999 Jan; 51(1):27-33. PubMed ID: 10197414
[TBL] [Abstract][Full Text] [Related]
5. Effects of absorption enhancers on cytoskeletal actin filaments in Caco-2 cell monolayers.
Sakai M; Imai T; Ohtake H; Azuma H; Otagiri M
Life Sci; 1998; 63(1):45-54. PubMed ID: 9667764
[TBL] [Abstract][Full Text] [Related]
6. Sodium caprate-induced increases in intestinal permeability and epithelial damage are prevented by misoprostol.
Brayden DJ; Maher S; Bahar B; Walsh E
Eur J Pharm Biopharm; 2015 Aug; 94():194-206. PubMed ID: 26026287
[TBL] [Abstract][Full Text] [Related]
7. Enhanced intestinal absorption of salmon calcitonin (sCT) from proliposomes containing bile salts.
Song KH; Chung SJ; Shim CK
J Control Release; 2005 Sep; 106(3):298-308. PubMed ID: 15979756
[TBL] [Abstract][Full Text] [Related]
8. Biopharmaceutical approaches for developing and assessing oral peptide delivery strategies and systems: in vitro permeability and in vivo oral absorption of salmon calcitonin (sCT).
Sinko PJ; Lee YH; Makhey V; Leesman GD; Sutyak JP; Yu H; Perry B; Smith CL; Hu P; Wagner EJ; Falzone LM; McWhorter LT; Gilligan JP; Stern W
Pharm Res; 1999 Apr; 16(4):527-33. PubMed ID: 10227707
[TBL] [Abstract][Full Text] [Related]
9. Colonic absorption of salmon calcitonin using tetradecyl maltoside (TDM) as a permeation enhancer.
Petersen SB; Nielsen LG; Rahbek UL; Guldbrandt M; Brayden DJ
Eur J Pharm Sci; 2013 Mar; 48(4-5):726-34. PubMed ID: 23354154
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of alkylmaltosides as intestinal permeation enhancers: comparison between rat intestinal mucosal sheets and Caco-2 monolayers.
Petersen SB; Nolan G; Maher S; Rahbek UL; Guldbrandt M; Brayden DJ
Eur J Pharm Sci; 2012 Nov; 47(4):701-12. PubMed ID: 22952065
[TBL] [Abstract][Full Text] [Related]
11. Melittin as a permeability enhancer II: in vitro investigations in human mucus secreting intestinal monolayers and rat colonic mucosae.
Maher S; Feighery L; Brayden DJ; McClean S
Pharm Res; 2007 Jul; 24(7):1346-56. PubMed ID: 17380268
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxicity of absorption enhancers in Caco-2 cell monolayers.
Sakai M; Imai T; Ohtake H; Otagiri M
J Pharm Pharmacol; 1998 Oct; 50(10):1101-8. PubMed ID: 9821655
[TBL] [Abstract][Full Text] [Related]
13. Tetradecylmaltoside (TDM) enhances in vitro and in vivo intestinal absorption of enoxaparin, a low molecular weight heparin.
Yang T; Arnold JJ; Ahsan F
J Drug Target; 2005 Jan; 13(1):29-38. PubMed ID: 15848952
[TBL] [Abstract][Full Text] [Related]
14. The use of polyion complex micelles to enhance the oral delivery of salmon calcitonin and transport mechanism across the intestinal epithelial barrier.
Li N; Li XR; Zhou YX; Li WJ; Zhao Y; Ma SJ; Li JW; Gao YJ; Liu Y; Wang XL; Yin DD
Biomaterials; 2012 Dec; 33(34):8881-92. PubMed ID: 22975427
[TBL] [Abstract][Full Text] [Related]
15. Melibiose, difructose anhydride III and difructose anhydride IV enhance net calcium absorption in rat small and large intestinal epithelium by increasing the passage of tight junctions in vitro.
Mineo H; Hara H; Shigematsu N; Okuhara Y; Tomita F
J Nutr; 2002 Nov; 132(11):3394-9. PubMed ID: 12421857
[TBL] [Abstract][Full Text] [Related]
16. 18β-Glycyrrhetinic acid altered the intestinal permeability in the human Caco-2 monolayer cell model.
Malekinejad M; Pashaee MR; Malekinejad H
Eur J Nutr; 2022 Oct; 61(7):3437-3447. PubMed ID: 35578042
[TBL] [Abstract][Full Text] [Related]
17. A permeation enhancer for increasing transport of therapeutic macromolecules across the intestine.
Gupta V; Hwang BH; Doshi N; Mitragotri S
J Control Release; 2013 Dec; 172(2):541-9. PubMed ID: 23680288
[TBL] [Abstract][Full Text] [Related]
18. Investigations of Piperazine Derivatives as Intestinal Permeation Enhancers in Isolated Rat Intestinal Tissue Mucosae.
Stuettgen V; Brayden DJ
AAPS J; 2020 Jan; 22(2):33. PubMed ID: 31989362
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of intestinal absorption enhancement and local mucosal toxicity of two promoters. I. Studies in isolated rat and human colonic mucosae.
Maher S; Kennelly R; Bzik VA; Baird AW; Wang X; Winter D; Brayden DJ
Eur J Pharm Sci; 2009 Nov; 38(4):291-300. PubMed ID: 19737613
[TBL] [Abstract][Full Text] [Related]
20. A mucoadhesive nanoparticulate system for the simultaneous delivery of macromolecules and permeation enhancers to the intestinal mucosa.
Makhlof A; Werle M; Tozuka Y; Takeuchi H
J Control Release; 2011 Jan; 149(1):81-8. PubMed ID: 20138935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
